Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-22-046250)

Filing Details

Accession Number:: 0001209191-22-046250
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-08-17 16:19:11
Reporting Period:: 2022-08-15

Accepted Time:: 2022-08-17 16:19:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1868734	Cincor Pharma Inc.	CINC	()	I0

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1574139	Sas Partners Sofinnova	7-11 Boulevard Haussmann Paris I0 75009		No	No	Yes	No
1849915	Ix Capital Sofinnova	7-11 Boulevard Haussmann Paris I0 75009		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-08-15	133,333	$30.00	4,220,979	No	4	P	Indirect	By Sofinnova Capital IX

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Sofinnova Capital IX

Footnotes

The shares are directly held by Sofinnova Capital IX ("SC IX"). Sofinnova Partners SAS ("Sofinnova Partners") is the management company of SC IX and may bedeemed to share voting and investment power over the shares held by SC IX. Sofinnova Partners disclaims beneficial ownership of these shares except to theextent of its pecuniary interest therein.